Lv1
90 积分 2023-06-08 加入
Ethnic differences in incidence of hepatitis B surface antigen seroclearance in a real-life multicenter clinical cohort of 4737 patients with chronic hepatitis B infection
3个月前
已关闭
Spontaneous loss of surface antigen among adults living with chronic hepatitis B virus infection: a systematic review and pooled meta-analyses
3个月前
已关闭
Diabetes-Alzheimer's connection in older age: SGLT2 inhibitors as promising modulators of disease pathways
3个月前
已完结
中国糖尿病合并慢性肾脏病临床管理共识
4个月前
已完结
Pharmacokinetics and Pharmacodynamics of Henagliflozin, a Sodium Glucose Co-Transporter 2 Inhibitor, in Chinese Patients with Type 2 Diabetes Mellitus
4个月前
已完结
Benefits of combining SGLT2 inhibitors and pioglitazone on risk of MASH in type 2 diabetes—A real‐world study
4个月前
已完结
Effectiveness of Ipragliflozin, a Sodium-Glucose Co-transporter 2 Inhibitor, as a Second-line Treatment for Non-Alcoholic Fatty Liver Disease Patients with Type 2 Diabetes Mellitus Who Do Not Respond to Incretin-Based Therapies Including Glucagon-like Peptide-1 Analogs and Dipeptidyl Peptidase-4 Inhibitors
4个月前
已完结
Six lessons learned from the use of SGLT2 inhibitors in patients with heart failure
4个月前
已完结
Safety and tolerability of empagliflozin and linagliptin combination therapy in patients with type 2 diabetes mellitus: a pooled analysis of data from five randomized, controlled clinical trials
4个月前
已完结
Nectin-4: a Tumor Cell Target and Status of Inhibitor Development
4个月前
已完结
皖公网安备34019202002308
